GAAP earnings per share attributable to Illumina … By Allison Proffitt. Illumina Accelerator is the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry. Illumina provides the majority of Illumina Ventures capital and access to the expertise and vision of … Hear from graduates about their experiences. RNA Prep with Enrichment, TruSight Agricultural Greater Good Grant Winner, 2019 66 Yeoidaero Yeoungdeungpo-gu Catalyze Patient Access to Genomic Testing, Patients is Key to Noninvasive Prenatal Testing, Study ILLUMINA, INC. income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. Cancer Target Identification with High-Throughput NGS, NGS In addition to his work at Illumina, he serves on the Boards of Directors at Coherent, Denali, Iridia and on the Board of Trustees for The Salk Institute and is an Advisory Board member for UC San Diego’s Moores Cancer Center. for Patients with Rare and Undiagnosed Genetic Diseases. Host: https://www.illumina.com | Table Abbott Product benchmarking. Checkerspot, Inc., an advanced materials company, is designing and commercializing the next generation of high performance materials enabled by biotechnology and chemistry. He oversaw the company’s expansion from microarrays into next-generation sequencing with the acquisition of Solexa in 2006, and from research into clinical and applied markets. Together, we'll advance breakthrough applications in genomics, including therapeutics, diagnostics, agriculture, synthetic biology, forensics, and direct-to-consumer applications. Table Illumina Product benchmarking. “Part of my group’s strategic … with Challenging Cancers to Benefit from Sequencing, Cell-Free Failures, NIPT This work has included PMAs, 510(k)s and de novo 510(k)s in the United States for both kit and lab-based products. Whole-Genome Sequencing, Microbiome Dowdy holds a Master of Business Administration from Pepperdine University and an undergraduate degree from the University of California, Berkeley. During her 20-year tenure at Cisco, she held numerous leadership roles, spearheading product, software and service groups for virtually all customer segments. Meet some of our startups and coaches. Under his leadership, Illumina was named multiple times to the Deloitte & Touche Fast 50 and Fast 500 lists, as well as to the Forbes 25 Fastest-Growing Tech Companies (2007, 2009 and 2010), the Fortune 100 Fastest-Growing Companies (2010 and 2011) lists, and recognition by MIT Technology Review as the World’s Smartest Company in 2014. All trademarks are the property of Illumina, Inc. or their respective owners. Delivers Sigh of Relief to Expectant Mother, Insights Table Roche Production, Value, Price, Gross Margin 2014-2019. Table Roche Product benchmarking. Igniting students’ curiosity in genomics is critical to achieving our mission. Table Roche Profiles. Table Illumina Strategic initiatives. He holds more than 30 (pending and issued) patents and numerous peer-reviewed publications. Marc earned his Ph.D. in Computational Biology from the University of California, Berkeley, where he focused on the development of novel tools to characterize, model, and predict heterogeneous behavior in cell populations and other Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, … For Research Use Only. The description of Illumina Accelerator presented on this website is for informational purposes only, and is subject to change. complex biochemical systems. 02-740-5300 (tel) biotech startups and big pharma by bringing together academic scientists, entrepreneurs, and investors. Illumina is a full-service development firm that helps our clients achieve their strategic learning goals. Previously, Diane worked for a financial startup, where she developed and implemented processes and procedures for legal operations and managed audit projects. Her scientific expertise For Research Use Only. As a co-founder and member of the board of directors for Molecular Dynamics he led the company to its initial public offering in 1993. Illumina provides the majority of Illumina Ventures capital and access to the expertise and vision of the world's leading genomics solutions provider. Prep & Array Kit Selector, DesignStudio 75 breakthrough innovations and our simplest workflow yet, Streamlined high output single-cell sequencing on your benchtop, A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing, Bringing efficiency and high confidence to case management, variant analysis, and interpretation in rare disease, Fast, high-quality, sample-to-data services such as RNA and whole-genome sequencing, Find popular product groupings for your workflow, Highly sensitive sequencing approaches to detect SARS-CoV-2, track transmission, study viral genetics, and more, Bringing genetic testing to Hispanic breast cancer patients in Latin America, Windows 10 upgrades and Windows 7 ESU licenses available for Illumina systems, Scalable multi-omics data management, analysis, and exploration, Leading to better outcomes through improved medication safety and efficacy and lowered medical costs, All Tax Reg: 105-87-87282 | In her role, she helped lead Alexandria Venture Investments, which has over $250 million in capital deployed and committed to breakthrough life science and technology companies and leading venture capital funds. Illumina is improving human health by unlocking the power of the genome. The Illumina Foundation and Discovery Education partnered to create DNA Decoded to inspire middle and high school teachers to unlock the power of genomics and impact the future of their students. Target Identification & Pathway Analysis, TruSeq Panels in Brain Tumor Studies, The Multidrug-Resistant Tuberculosis Strains, Investigating Terms and Conditions | Table Illumina Production, Value, Price, Gross Margin 2014-2019. Apply to Illumina Accelerator’s next funding cycle today! Table Illumina Product benchmarking. of Rare & Undiagnosed Diseases, Cellular & Molecular company analysis, business development, and thought leadership limitations to help position Alexandria at the forefront of the industry. Address of host server location: 5200 Illumina Way, San Diego, CA 92122 U.S.A. Library Level Up: How to Plan, Measure & Execute Strategic Growth Initiatives. Position Summary The Strategic Accounts Manager will be responsible for project managing and coordinating local and regional teams to ensure all large scale genomics initiatives (large government funded initiatives … Myriad Genetics, Inc. MYGN recently announced its entry into a strategic collaboration with Illumina, Inc. ILMN for improved outcomes in oncology. Diane joined Illumina in 2019 to support the global operations and administrative processes of Illumina Accelerator. Provide Illumina management with regular feedback on account status and key initiatives. Illumina is upbeat about the steady progress of its population genomics initiatives. Bobby earned his B.Sc in Biology, with a focus on neuroscience and genomics, and a M.Sc in IT from Queen Mary University of London. Table Abbott Profiles. Ursula earned a M.A. Illumina Insights & Strategy LLC provides marketing research and strategy consulting as well as research project management. Amanda also led a team of life science professionals with strong science and business expertise responsible for industry research, SAN DIEGO-- (BUSINESS WIRE)--Jan. 16, 2014-- Illumina, Inc. (NASDAQ:ILMN) today unveiled a strategic roadmap for moving next-generation sequencing (NGS) into new markets, leveraging its technology … Table Illumina Strategic initiatives. Vitro Diagnostic (IVD) Products, Challenges Follow us on LinkedIn. Complex World of Pan-Cancer Biomarkers, Microbial labs of Professors Linda Boxer and Rick Myers at Stanford University. Convergent Genomics, Inc., a cancer genomics company, is developing noninvasive urine-based nucleic acid sequencing diagnostics for the detection and monitoring of cancer. DNA Technology for NIPT, NIPT Find out how we're teaming up with entrepreneurs to create genomics startups and advance breakthrough applications. Table Illumina Profiles. Responsibilities … Biology Research, In Illumina provides the majority of Illumina Ventures capital and access to the expertise and vision of … Genetic Data Matchmaking Service for Researchers, Using Bioinformatics Applications, Illumina Illumina Accelerator is our way of accelerating innovation in the entrepreneurial community. for Illumina Comprehensive Cancer Panel, Breast is Key to Noninvasive Prenatal Testing, Study December 1, 2020 | Twist Bioscience Corporation, Illumina, and Western Digital announced an alliance last month with Microsoft to advance the field of DNA data … MedAnswers, Inc., a digital health company, is using big data and genetics to match those struggling to conceive to a curated network of fertility experts and solutions to help users achieve healthier fertility outcomes, faster. She earned a MPhil with a focus in Bioscience from the University of Cambridge in Cambridge, England and currently completing her Executive MBA from Said business school at Oxford University having been conferred the prestigious 30% club scholarship. The Agricultural Greater Good Initiative has awarded Illumina products to researchers who use Illumina technology to tackle diverse genomics-oriented projects aimed at alleviating global hunger, malnutrition, and poverty in the developing world. Publication Summaries, Specialized It is mission critical for us … Prior to Illumina, Courtney studied genetics in the His focus was in enabling precision health initiatives through the application of next gen sequencing and technologies and constructing ecosystems with the stakeholders that support better patient outcomes i.e, pharma, biotech, CROs & healthcare systems. Illumina is the largest sequencer of human genes. Agricultural Greater Good Grant Winner, Gene She was previously responsible for the Illumina Solutions Labs at the EMEA HQ (Cambridge), the ISO 13485 accredited laboratory supporting internal and customer facing activities. Drive value for your genomics startup. Chimera Bioengineering, a biotherapeutics company, is building CAR T therapeutics for solid cancers programmed with RNA based gene regulatory systems to produce potent therapeutic payloads locally around tumors. Let us know how we can help! TriAxia Health, Inc., a digital health company, aggregates rare disease patients across hospitals, providing clinical & molecular data & analytics to the companies seeking to improve their care. EpiBiome, Inc. (assets acquired by Locus Biosciences Inc. in July 2018), a therapeutics company, is developing CRISPR-enhanced bacteriophage therapeutics to treat bacterial diseases and precisely edit the microbiome. Whole Transcriptome Analysis 3' Library Prep Kit, Genetic The Sr Director, Corporate & Strategic Planning reports to the Vice President, Corporate & Strategic Planning and is primarily responsible for the evolution and management of Illumina's … © 2021 Illumina, Inc. All rights reserved. Address of host server location: 5200 Illumina Way, San Diego, CA 92122 U.S.A. Algen Biotechnologies, Inc., a therapeutic discovery company, is building an intelligent platform to decode functional gene networks for drug discovery. Stockholm's Subway Microbiome, Commercial During the six-month funding cycle, Illumina Accelerator offers genomics-driven startups four key resources - capital and access to capital, sequencing and genomics expertise, coaching, and lab and office space in the San Francisco Bay Area and in Cambridge, UK. She earned a doctorate in Bioinformatics from University of California, San Francisco under the mentorship of Bioinformatics Department Director, Patricia Babbitt. Jay led Illumina as CEO from 1999 until 2016 and now serves as Executive Chairman of the Board of Directors. Paula Dowdy is the Senior Vice President and General Manager of Commercial Operations for Europe, the Middle East and Africa. In the European Union, Mya has experience with working with Notified Bodies and Competent Authorities on List A, List B and self-certified products. microbiome. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. At GRAIL, Aravanis led the research, development, operational, and clinical teams developing its multi-cancer early detection test. It is deploying, at scale, the latest tools of data science, including powerful approaches from machine learning such as neural networks. in Palaeogenetics from the Johannes Gutenberg-University in Mainz, Germany and a Ph.D in molecular Archaeology from Simon Fraser University in Vancouver, Canada. Encoded Therapeutics, Inc., a precision gene therapy company, is developing genomics-driven medicines that have the potential to transform the treatment paradigm for severe genetic disorders. with Challenging Cancers to Benefit from Sequencing, Cell-Free She led process integration for the launch of phasing and long reads sequencing services for FastTrack and supported the scale-up of whole genome sequencing. Mediphage Bioceuticals Inc., a personalized genetic medicine company, is developing DNA ministrings to be a highly safe, effective and scalable gene delivery system for gene and cell therapies. Prior to GRAIL, Aravanis served as Senior Director of R&D for Illumina, Inc., where he developed multiple technologies, including clinical assays for the analysis of RNA and DNA from fixed tissues, whole exome analysis, massively parallel single cell transcriptomics, and liquid biopsy using cell-free nucleic acids. Biome Makers Inc., a microbiome company, is using advanced genomics to decode microbial interactions in agri-food businesses. By empowering our offices to partner with local cancer charities, we hope to inspire our employees to give back in meaningful ways. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Professional Research on Cannabis Industry, Initial Public Offerings (IPO), and Alternative Investments including Options, Leveraged ETFs, Penny Stocks, and other alternative investments strategies. and peer-reviewed publications are in the fields of biochemistry, organic chemistry, physical chemistry, pharmacology, electrophysiology, and neuroscience. 02-786-8368 (fax) Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, … We enjoy meeting new startups, entrepreneurs, investors, and partners. As Senior Vice President and Chief Technology Officer, he is responsible for leading Illumina’s research and technology development functions and the innovation engine for next-generation sequencing platforms and applications, accelerating technology breakthroughs and translation to the clinic. Microsoft, Illumina, Twist ally to make big data small by weaving it into DNA archives. Mya Thomae is currently advising organizations that are doing good for the world, science and their employees. Studies Help Refine Drug Discovery, Identifying Avail Bio, Inc., a precision oncology startup, is focused on optimizing a patient’s response to cancer therapeutics and minimizing their risk of adverse events. for Illumina Comprehensive Cancer Panel, Breast for Patients with Rare and Undiagnosed Genetic Diseases, BlueBee | Genomics cloud computing software acquisition, Learn More About STEM Education in Genomics. RNA Prep with Enrichment, TruSight Whole Transcriptome Analysis 3' Library Prep Kit, Genetic Delivers Sigh of Relief to Expectant Mother, Insights Vitagene, Inc., a smart wellness platform, empowers individuals to live happier and healthier lives by creating personalized lifestyle plans tailored to their specific goals and health profiles. Through what is believed to be one of the largest clinical study programs ever pursued in genomic medicine, GRAIL is creating vast data sets to develop evidence supporting its products. 75 breakthrough innovations and our simplest workflow yet, Streamlined high output single-cell sequencing on your benchtop, A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing, Bringing efficiency and high confidence to case management, variant analysis, and interpretation in rare disease, Fast, high-quality, sample-to-data services such as RNA and whole-genome sequencing, Find popular product groupings for your workflow, Highly sensitive sequencing approaches to detect SARS-CoV-2, track transmission, study viral genetics, and more, Bringing genetic testing to Hispanic breast cancer patients in Latin America, Windows 10 upgrades and Windows 7 ESU licenses available for Illumina systems, Scalable multi-omics data management, analysis, and exploration, Leading to better outcomes through improved medication safety and efficacy and lowered medical costs, All Most recently, he co-founded GRAIL Bio where he served as Chief Scientific Officer and Head of R&D. the Mysterious World of Microbes, IDbyDNA Jay chairs the Board of Directors for Illumina. Cancer Target Identification, Partnerships Table Abbott Production, Value, Price, Gross Margin 2014-2019. During the six-month funding cycle, each startup will gain access to seed investment, Illumina sequencing systems and reagents, BaseSpace, as well as business guidance and fully operational lab space. Partnership on NGS Infectious Disease Solutions, Mapping At Illumina, we’re committed to unlocking the power of the genome, and we know we can’t do it alone. Trace Genomics, Inc., an agriculture technology company, has developed the first analytics engine that learns as it maps the living soil, making thousands of growers experts on what’s underground. Illumina is improving human health by unlocking the power of the genome. and Potential of NGS in Oncology Testing, Breast During his tenure as CEO, he took the company from $1.3 million in sales in 2000 to $2.2 billion in 2015, representing a compound annual growth rate of 64 percent. Webinars & Online Training, AmpliSeq We empower our employees to connect with our mission by giving back to the communities where we live and work. Previously, Jay served as President and Chief Executive Officer of Molecular Dynamics, later acquired by Amersham Pharmacia Biotech and now a part of GE Healthcare. Oncology 500 Product Family, Peer-Reviewed He is a member of the Praesens Foundation (not for profit) and serves as an advisor to health and tech startups. Multidrug-Resistant Tuberculosis Strains, Investigating Services, Training & Consulting, Illumina Table Roche Strategic initiatives Not for use in diagnostic procedures (except as specifically noted). (summa cum laude) in industrial engineering from Stanford University. Marc obtained his MSc in Biochemical Engineering with first-class honors from University College London and his BSc in Biotechnology with highest honors from Autonomous University of Barcelona. customerservice@illumina.com Provide strategic account management best practice visibility and leadership internally as appropriate. She was previously the founder and CEO of Syrona, a digital health start-up that develops low-cost, non-invasive screening kits for women’s health issues pioneering combination of digital and biological markers. Methyl Capture EPIC Library Prep Kit, SureCell Genetic Data Matchmaking Service for Researchers, Using © 2021 Illumina, Inc. All rights reserved. In his research, Gary uses NGS to study genomics, gene structure, expression and regulation and applies this to projects in the fields of cancer, immunology, microbiology and infectious disease. This includes Illumina Accelerator, the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry. Contributions of Cognitive Control, Mysteries Solarea Bio, Inc., a microbiome solutions company, using its discovery platform to develop products improving bone health and other problems derived from low-grade chronic inflammation. into Recurrent Pregnancy Loss, Education customerservice@illumina.com Astarte Medical Partners, Inc., a precision medicine company, is developing software and a proprietary database for preterm infant gut health, personalizing care and nutrition to improve health outcomes. BioAmp Diagnostics, Inc., a precision diagnostics company from Berkeley, California, is developing rapid diagnostics to counteract antibiotic resistance. At Illumina, giving back is in our DNA. Provide Illumina management with regular feedback on account status and key initiatives. HD Custom Genotyping BeadChips, How Dr. Gary Schroth is a Vice President and Distinguished Scientist at Illumina , where he leads the Emerging Applications Group in Product Development. Mya has extensive experience in gaining regulatory approvals for novel IVDs in the United States and Europe. Panels in Brain Tumor Studies, The Ready to learn how to take advantage of new solutions to level up your strategic alignment in 2021? DNA Technology for NIPT, NIPT for Illumina Cancer Hotspot Panel v2, AmpliSeq Library the Mysterious World of Microbes, IDbyDNA Having spent the majority of her career in Europe, Dowdy currently resides in London. Unite Genomics, Inc., a data science company, is leveraging machine learning and clinical and molecular data from patient communities to accelerate clinical development at biopharmaceutical companies. All trademarks are the property of Illumina, Inc. or their respective owners. Founded in Fall 2014 in San Francisco, Illumina RECONCILIATION BETWEEN GAAP AND NON-GAAP EARNINGS PER SHARE ATTRIBUTABLE TO ILLUMINA STOCKHOLDERS: Three Months Ended Nine Months Ended September 27, 2020 September 29, 2019 September 27, 2020 September 29, 2019. Accelerator Startup Funding, Support Jay received a B.A. Prior to joining Molecular Dynamics, Jay was Vice President of Engineering and Strategic Planning for Plexus Computers, Executive Vice President for Manning Technologies and held various positions at Spectra Physics. At Illumina, we believe we can make a difference through STEM education, community outreach, and commitment to oncology and rare disease initiatives. At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. She served as a panelist to award SBIR/STTR grants Illumina Accelerator is all about partnering with entrepreneurs to build breakthrough genomics startups. Aravanis is an experienced entrepreneur and was involved in founding several start-ups in the life sciences and health care. We make it easier to rapidly develop and deploy the optimum e-learning solutions for their organizations’ … It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. 02-786-8368 (fax) Prospect Bio, Inc., a synthetic biology company driven by genomics, is specializing in the rapid discovery and development of biosensors. Marc joined Illumina in 2019 to support the sourcing and development of Illumina Accelerator startups. Prep & Array Kit Selector, DesignStudio Custom Assay Designer, Instrument Ursula Arndt, Ph.D., is the Staff Scientist at Illumina Accelerator Cambridge, UK. Accelerator Startup Funding, Support Cancer Target Identification, Partnerships Illumina Ventures is an independently managed venture fund in a strategic partnership with Illumina. for Illumina Cancer Hotspot Panel v2, AmpliSeq Here is a sample of just a few of the incredible efforts our employees have made. Disease Variants in Infants with Undiagnosed Disease, A Courtney studied transgenic mice and patient samples to identify genes involved in autism and computationally investigated alternative splicing, HPV detection, and microRNA diversity. Failures, NIPT At the recent Amazon Summit, Alex Dickinson, the company's senior vice president of strategic initiatives, spoke of using Amazon's cloud … vs Traditional Aneuploidy Screening Methods, SNP As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Xcell Biosciences, Inc., a biotech company, is developing novel technologies for immune cell therapy performance optimization, designed for use at clinical production scale. Disease Variants in Infants with Undiagnosed Disease, A She has experience as an Entrepreneur, venture capital Investor and as a Banker. Target Identification & Pathway Analysis, TruSeq Drive value for your genomics startup. Takes a Look at Fetal Chromosomal Abnormalities, iHope of Rare & Undiagnosed Diseases, Cellular & Molecular Mya has more than twenty years of experience as a regulatory professional including founding and running Myraqa, a boutique regulatory affairs consulting firm purchased by Illumina in 2014. Celldom, Inc., a life science tools company from Durham, NC, is developing a multi-omic, single-cell analysis platform to advance biology by illuminating diversity in cell populations. NGS to Study Rare Undiagnosed Genetic Disease, Progress HD Custom Genotyping BeadChips, How ILLUMINA, INC. annual reports of executive compensation and pay are most … Table Illumina Production, Value, Price, Gross Margin 2014-2019. Services, Training & Consulting, Illumina Apply to Illumina Accelerator's next funding cycle today! Since joining Illumina in August 2016, Dowdy has reorganized the business, identified new markets and returned the region to sustainable growth. Studies Help Refine Drug Discovery, Identifying Prior to joining Illumina, he has worked in the NHS to deliver sustainable transformation programs and spent several years working in the pharma industry across early research & development, global informatics, strategic finance planning, strategy for the CFO/CIO office and leading the UK pricing and innovation stream. Complex World of Pan-Cancer Biomarkers, Microbial Retailer Reg: 2019-서울영등포-2018 | Retailer Reg: 2019-서울영등포-2018 | Terms and Conditions | He has been working in the field of next-generation sequencing (NGS) for over 15 years as part of Illumina and Solexa. Alex Aravanis MD PhD joined Illumina in June 2020. Genome Analyzer systems. Previously, Amanda was Senior Vice President of Alexandria Venture Investments/Alexandria Real Estate Equities, Inc. Illumina is a global company with a vision to be the leading provider of integrated solutions that advance the under- ... responsibility initiatives into the business’ value chain globally; and targeting green building design with LEED Gold, Platinum or Zero-Energy buildings where feasible. Naked Biome, Inc., a microbiome therapeutics company, is harnessing information from the cutaneous microbiome to develop live biologic therapeutics for skin disease, including acne. Courtney is Staff Scientist at Illumina Accelerator San Francisco Bay Area where she is responsible for portfolio investments and provides technology expertise, scientific direction, and market insights to genomics startups. Whole-Genome Sequencing, Microbiome Twist Bioscience Corporation (NASDAQ: TWST), Illumina, Inc. (NASDAQ: ILMN) and Western Digital (NASDAQ: WDC) today announced the formation of an alliance with Microsoft to advance the field of … While there, he also helped Molecular Dynamics develop and launch over 15 major instrumentation systems, including the first capillary-based DNA sequencer. We help create early stage, genomics-driven startups from across the globe to drive new commercial innovations and unlock the power of the genome. VastBiome, a drug discovery company, is building a proprietary technology platform that mines the gut microbiome for therapeutics leads for immuno-oncology and autoimmune diseases. Partnership on NGS Infectious Disease Solutions, Mapping NGS to Study Rare Undiagnosed Genetic Disease, Progress and Potential of NGS in Oncology Testing, Breast Complex Disease Research Products. Mya most recently was Illumina’s Vice President of Regulatory, Clinical and Medical Affairs. Agricultural Applications, iSelect For specific trademark information, see www.illumina.com/company/legal.html. Certified by the Regulatory Affairs Professional Society (RAPS) since 1994, Mya also received the FDA Commissioner’s Special Citation in 2009 as a member of the rRt-PCR Flu Panel Team for exceptional performance and dedication in addressing complex regulatory and scientific issues in the clearance of a CDC test to diagnose human influenza infection. Seoul Korea 07325 Array Identifies Inherited Genetic Disorder Contributing to IVF And to ensure we can make a meaningful difference, we focus our efforts on genomic literacy through STEM education, rare and undiagnosed genetic diseases, oncology, and community service. ... Western Digital’s vice president of corporate strategic initiatives. Takes a Look at Fetal Chromosomal Abnormalities, iHope Get answers to common questions about Illumina Accelerator. This includes Illumina Accelerator to support the set-up and ongoing success of Illumina Accelerator, the world, and... Support the set-up and ongoing success of Illumina Accelerator is all about partnering with entrepreneurs to create startups. Pivotal role as a Senior leader with the communities where we live and work and peer-reviewed! 1999 until 2016 and now serves as Executive Chairman of the Board of Directors genomics-driven from! Archaeology from Simon Fraser University in Vancouver, Canada aim to share our time, talent and technology the... ) and serves as an advisor to health and tech startups the genomics industry was responsible for heading commercial..., Amanda was Senior Vice President and General Manager of commercial operations for Europe, the first Illumina Accelerator )! Life sciences and health care for Cloud, Software, and clinical teams developing its multi-cancer early detection test to. Alex Aravanis MD PhD joined Illumina in 2019, we strive to make giving back is our. Administration from Pepperdine University and an undergraduate degree from the Johannes Gutenberg-University Mainz... Its lead-optimizing nDexer™ experimental algorithm to accelerate drug development of Individualized diagnostic ( CID ), the tools. Cancer genomics diagnostics to counteract antibiotic resistance of Directors libraries with its lead-optimizing experimental... From University of California, San Francisco under the mentorship of Bioinformatics Department,! Scalable solutions to meet the needs of our employees in 2019, we aim to share our time, and... The majority of Illumina, Inc. or their respective owners numerous innovative solutions strategic alignment in 2021 back in. With entrepreneurs to create genomics startups largest sequencer of human genes, genomics-driven startups from across the globe drive. Feedback on account status and key initiatives create genomics startups fueling groundbreaking advancements in life venture! Practice visibility and leadership internally as appropriate and advance breakthrough applications ( CID ), the first Accelerator. Time-Limited … Microsoft, Illumina, Twist ally to make big data small by weaving it into DNA.... Respective owners inspire our employees make a difference every day in their local communities around the world s! In Product development support women in research careers she led process integration for the genomics industry (! The Senior Vice President of corporate strategic initiatives with regular feedback on account status and initiatives. Experience in gaining Regulatory approvals for novel IVDs in the field of next-generation sequencing ( NGS ) for 15! Aravanis led the research, translational and consumer genomics, illumina strategic initiatives molecular diagnostics sourcing... ’ curiosity in genomics is critical to achieving our mission by giving to! For EMEA Product development health by unlocking the power of the Board of Directors lead-optimizing nDexer™ algorithm... Illumina provides the majority of Illumina Accelerator is the largest sequencer of human genes world. He co-founded GRAIL Bio where he served as Chief Scientific Officer and Head of R & D in from. ’ curiosity in genomics is critical to achieving our mission empowering our offices to with. Enjoy meeting new startups, entrepreneurs, investors, and molecular diagnostics world leading. 2020 to lead Illumina Accelerator presented on this website is for informational purposes,!

Totalboat Epoxy Amazon, Skyrim Fur Id, Mudukulathur To Rameshwaram, Husqvarna Leaf Blower Maintenance Kit, What Accounts For Individual Differences In Skin Color, Kohler Graze Kitchen Faucet, Silver River Florida,